Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome

Journal of Pain

Volumn 13, Issue 11, 2012, Pages 1068-1074

  Fernández De Las Peñas, César ^a   Ambite Quesada, Silvia ^a   Gil Crujera, Antonio ^a   Cigarán Méndez, Margarita ^a   Peñacoba Puente, Cecilia ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

anxiety; COMT; depression; Fibromyalgia; pain; pressure pain; Val158Met

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ANXIETY DISORDER; ARTICLE; CARPOMETACARPAL JOINT; DEPRESSION; DISABILITY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FUNCTIONAL STATUS; GENOTYPE; HEREDITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; NOCICEPTION; PAIN ASSESSMENT; PAIN THRESHOLD; PHENOTYPE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; TIBIALIS ANTERIOR MUSCLE; ZYGAPOPHYSEAL JOINT;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANXIETY; CATECHOL O-METHYLTRANSFERASE; DEPRESSION; DISABILITY EVALUATION; DNA; FEMALE; FIBROMYALGIA; GENOTYPE; HUMANS; MIDDLE AGED; PAIN MEASUREMENT; POLYMORPHISM, GENETIC; PRESSURE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; YOUNG ADULT;

EID: 84868197171     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2012.08.001     Document Type: Article

References (47)

1. F.R. Barbosa, J.B. Matsuda, M. Mazucato, S. de Castro França, S.M. Zingaretti, L.M. da Silva, N.M. Martinez-Rossi, M.F. Júnior, M. Marins, and A.L. Fachin Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients Rheumatol Int 32 2012 427 430
2. R. Bennett The Fibromyalgia Impact Questionnaire (FIQ): A review of its development, current version, operating characteristics and uses Clin Exp Rheumatol 23 2005 S154 S156
3. P. Bijur, W. Silveer, and J.E. Gallagher Reliability of the visual analogue scale for measurement of acute pain Acad Emerg Med 8 2001 1153 1157
4. C.S. Burckhardt, S.R. Clark, and R.M. Bennett The Fibromyalgia Impact Questionnaire: Development and validation J Rheumatol 18 1991 728 733
5. E.P. Calandre, J. García-Carrillo, J.M. García-Leiva, F. Rico-Villademoros, R. Molina-Barea, and C.M. Rodríguez López Subgrouping patients with fibromyalgia according to the results of the Fibromyalgia Impact Questionnaire: A replication study Rheumatol Int 31 2011 1555 1559
6. L.S. Chesterson, J. Sim, C.C. Wright, and N.E. Foster Inter-rater reliability of algometry in measuring pressure pain thresholds in healthy humans, using multiple raters Clin J Pain 23 2007 760 766
7. H. Cohen, L. Neumann, Y. Glazer, R.P. Ebstein, and D. Buskila The relationship between a common Catechol-O-methyltransferase (COMT) polymorphism val (158) met and fibromyalgia Clin Exp Rheumatol 27 2009 S51 S56
8. J.A. Desmeules, C. Cedrashi, E. Rapiti, E. Baymgartner, A. Finckh, P. Cohen, P. Dayer, and T.L. Vischer Neurophysiologic evidence for a central sensitization in patients with fibromyalgia Arthritis Rheum 48 2003 1420 1429
9. J. Desmeules, V. Piguet, M. Besson, J. Chabert, E. Rapiti, M. Rebsamen, M.F. Rossier, F. Curtin, P. Dayer, and C. Cedraschi Psychological distress in fibromyalgia patients: A role for catechol-O-methyl-transferase Val158met polymorphism Health Psychol 31 2012 242 249
10. J.B. de Souza, P. Goffaux, N. Julien, S. Potvin, J. Charest, and S. Marchand Fibromyalgia subgroups: proWling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study Rheumatol Int 29 2009 509 515
11. L. Diatchenko, G.D. Slade, A.G. Nackley, K. Bhalang, A. Sigurdsson, I. Belfer, D. Goldman, K. Xu, S.A. Shabalina, D. Shagin, M.B. Max, S.S. Makarov, and W. Maixner Genetic basis for individual variations in pain perception and the development of a chronic pain condition Hum Mol Genet 14 2005 135 143
12. E.M. Drabant, A.R. Hariri, A. Meyer-Lindenberg, K.E. Munoz, V.S. Mattay, B.S. Kolachana, M.F. Egan, and D.R. Weinberger Catechol-o-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation Arch General Psychiatr 63 2006 1396 1406
13. M.F. Egan, T.E. Goldberg, B.S. Kolachana, J.H. Callicott, C.M. Mazzanti, R.E. Straub, D. Goldman, and D.R. Weinberger Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia Proc Natl Acad Sci USA 98 2001 6917 6922
14. J. Esteve-Vives, J. Rivera-Redondo, I. Salvat-Salvat, M. Gracia-Blanco, and C. Alegre-Miguel Propuesta de una versión de consenso del Fibromyalgia Impact Questionnaire (FIQ) para la población española Reumatol Clin 3 2007 21 24
15. C. Fernández-de-Las-Peñas, C. Fernández-Lao, I. Cantarero-Villanueva, S. Ambite-Quesada, I. Rivas-Martínez, R. Del Moral-Avila, and M. Arroyo-Morales Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors Breast Cancer Res Treat 133 2012 405 412
16. P.H. Finan, A.J. Zautra, M.C. Davis, K. Lemery-Chalfant, J. Covault, and H. Tennen COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia Pain 152 2011 300 307
17. F.J. García-Fructuoso, J.I. Lao-Villadóniga, K. Beyer, and C. Santos Relationship between catechol-O-methyltransferase genotypes and fibromyalgia severity Reumatol Clin 2 2006 168 172
18. S. Gürsoy, E. Erdal, H. Herken, E. Madenci, B. Alasehirli, and N. Erdal Significance of the catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome Rheumatol Int 23 2003 104 107
19. M.A. Hamburg, and F.S. Collins The path to personalized medicine N Engl J Med 363 2010 301 304
20. M.J. Herrero, J. Blanch, J.M. Pei, J. De Pablo, L. Pintor, and A. Bulbena A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population Gen Hosp Psych 25 2003 277 283
21. C. Herrmann International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results J Psychosom Res 42 1997 17 41
22. S. Holm A simple sequentially rejective multiple test procedure Scand J Stat 6 1979 65 70
23. L.M. Jacobsen, G.S. Eriksen, L.M. Pedersen, and J. Gjerstad Catechol-O-methyltransferase (COMT) inhibition reduces spinal nociceptive activity Neurosci Lett 473 2010 212 215
24. M.P. Jensen, J.A. Turbner, J.M. Romano, and L. Fisher Comparative reliability and validity of chronic pain intensity measures Pain 83 1999 157 162
25. S.G. Khasar, P.G. Green, F.J. Miao, and J.D. Levine Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat Eur J Neurosci 17 2003 909 915
26. Y.H. Lee, S.J. Choi, J.D. Ji, and G.G. Song Candidate gene studies of fibromyalgia: A systematic review and meta-analysis Rheumatol Int 32 2012 417 426
27. P. Mannisto, and S. Kaakkola Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors Pharmacol Rev 51 1999 593 628
28. J.B. Matsuda, F.R. Barbosa, L.J. Morel, C. França Sde, S.M. Zingaretti, L.M. da Silva, A.M. Pereira, M. Marins, and A.L. Fachin Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: Triggers of fibromyalgia? Rev Bras Reumatol 50 2010 141 149
29. S.A. McLean, L. Diatchenko, Y.M. Lee, R.A. Swor, R.M. Domeier, J.S. Jones, C.W. Jones, C. Reed, R.E. Harris, W. Maixner, D.J. Clauw, and I. Liberzon Catechol-o-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision J Pain 12 2011 101 107
30. P. Montoya, P. Pauli, A. Batra, and G. Wiedemann Altered processing of pain-related information in patients with fibromyalgia Eur J Pain 9 2005 293 303
31. A.G. Nackley, K.T. Tan, K. Fecho, P. Flood, L. Diatchenko, and W. Maixner Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both b2- and b3-adrenergic receptors Pain 128 2007 199 208
32. I.E. Nagel, C. Chicherio, S.C. Li, T. von Oertzen, T. Sander, A. Villringer, H.P. Heekeren, L. Bäckman, and U. Lindenberger Human aging magnifies genetic effects on executive functioning and working memory Front Hum Neurosci 2 2008 1
33. F. Petzke, D.J. Clauw, K. Ambrose, A. Khine, and R.H. Gracely Increased pain sensitivity in fibromyalgia: Effects of stimulus type and mode of presentation Pain 105 2003 403 413
34. T.T. Rakvag, J.R. Ross, H. Sato, F. Skorpen, S. Kaasa, and P. Klepstad Genetic variation in the Catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain Mol Pain 4 2008 64
35. B.J. Small, K.S. Rawson, E. Walsh, H.S. Jim, T.F. Hughes, L. Iser, M.A. Andrykowski, and P.B. Jacobsen Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors Cancer 117 2011 1369 1376
36. M.N. Smolka, G. Schumann, J. Wrase, S.M. Grüsser, H. Flor, K. Mann, D.F. Braus, D. Goldman, C. Büchel, and A. Heinz Catechol-o- methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex J Neuros 25 2005 836 842
37. R. Staud, and M. Rodriguez Mechanisms of disease: Pain in fibromyalgia syndrome Nat Clin Pract Rheumatol 2 2006 90 98
38. R. Staud Predictors of clinical pain intensity in patients with fibromyalgia syndrome Curr Pain Headache Rep 9 2005 316 321
39. R.D. Strous, N. Bark, M. Woerner, and H.M. Lachman Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia Biol Psychiatry 41 1997 493 495
40. A.C. Syvanen, C. Tilgmann, J. Rinne, and I. Ulmanen Genetic polymorphism of catechol-O-methyltransferase (COMT): Correlation of genotype with individual variation of SCOMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland Pharmacogenetics 7 1997 65 71
41. B. Tander, S. Gunes, O. Boke, G. Alayli, N. Kara, H. Bagci, and F. Canturk Polymorphisms of the serotonin-2A receptor and catechol-O- methyltransferase genes: A study on fibromyalgia susceptibility Rheumatol Int 28 2008 685 691
42. L. Vanderweeen, R.B. Oostendorp, P. Vaes, and W. Duquet Pressure algometry in manual therapy Man Ther 1 1996 258 265
43. G. Vargas-Alarcón, J.M. Fragoso, D. Cruz-Robles, A. Vargas, A. Vargas, J.I. Lao-Villadóniga, F. García-Fructuoso, M. Ramos-Kuri, F. Hernández, R. Springall, R. Bojalil, M. Vallejo, and M. Martínez-Lavín Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia Arthritis Res Ther 9 2007 R110
44. F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, P. Tugwell, S.M. Campbell, M. Abeles, and P. Clark The American College of Rheumatology 1990 criteria for classification of fibromyalgia: Report of the multicenter criteria committee Arthritis Rheum 33 1990 160 170
45. F. Wolfe, D.J. Clauw, M.A. Fitzcharles, D.L. Goldenberg, R.S. Katz, P. Mease, A.S. Russell, I.J. Russell, J.B. Winfield, and M.B. Yunus The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity Arthr Care Res 62 2010 600 610
46. A.S. Zigmond, and R.P. Snaith The hospital anxiety and depression scale Acta Psychiatr Scand 67 1983 361 370
47. J.K. Zubieta, M.M. Heitzeg, Y.R. Smith, J.A. Bueller, K. Xu, Y. Xu, R.A. Koeppe, C.S. Stohler, and D. Goldman COMT val158 met Genotype affects μ-opioid neurotransmitter responses to a pain stressor Science 299 2003 1240 1243